Abstract
This chapter discusses the chemical pathways, metabolic actions, substrates, inducers, and inhibitors of the uridine 5′-diphosphate glucuronosyltransferases, also known as UGTs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hiller A, Nguyen N, Strassburg CP. Retigabine N-glucuronidation and its potential role in enterohepatic circulation. Drug Metab Dispos. 1999;27(5):605–12.
Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet. 1999;37(6):435–56.
Linnet K. Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes. Hum Psychopharmacol. 2002;17(5):233–8.
Ethell BT, Anderson GD, Burchell B. The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol. 2003;65(9):1441–9.
Chau N, Elliot DJ, Lewis BC, et al. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibtion, and molecular modeling studies. J Pharmacol Exp Ther. 2014;349(1):126–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sandson, N.B. (2015). Uridine 5′-diphospho-glucuronoslytransferases (UGTs): Conjugating Cousins. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7495-1_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7494-4
Online ISBN: 978-1-4614-7495-1
eBook Packages: MedicineMedicine (R0)